Spineway
-
Spine
Spineway: a week dedicated to medical excellence with more than 20 surgeons trained
Ecully, November 14, 2024- The Spineway Group, a , specialist in innovative implants for the treatment of severe spine disorders,…
Read More » -
Financial
Spineway : Continued organic growth – Nine-month 2024 revenue of €9.1 million (+21%)
Ecully, October 15, 2024 – SPINEWAY Continued organic growthNine-month 2024 revenue of €9.1 million (+21%) In thousands of euros20242023Change%Q1 revenue3,0702,39828%Q2…
Read More » -
Spine
Strengthened presence in Europe
Spineway continues its sales and marketing efforts in Europe Press release – Ecully, July 8, 2024 – The Spineway Group, a…
Read More » -
Spine
Partnership of Spineway with the SFCR for June 24 congress
SPINEWAY partners with the Société Française de Chirurgie du Rachis (SFCR) Congress in Montpellier, France Ecully, June 10, 2024 –…
Read More » -
Spine
Spineway-Partnership with Key Opinion Leaders and successful trainings
SPINEWAY organizes surgical training sessions in the use of ESP and KAPHORN implants Ecully, May 30, 2024 – The Spineway…
Read More » -
Financial
Spineway-Growth of 28% of 2024 first quarter revenue
Ecully, April 16, 2024 First-quarter 2024 revenue of €3.1 millionGrowth of 28% compared with 2023 first quarter In thousands of…
Read More » -
Financial
SPINEWAY : 2023 annual results
Ecully, February 7, 2024 – 2023 revenue of €10.5 million (+42%) Gross margin steady at 69% Net income heavily impacted…
Read More » -
Financial
Spineway-Increase of 2023 revenue at €10.5 million
Ecully, January 25, 2024 – 2023 revenue of €10.5 million In thousands of eurosUnaudited data20232022% changeQ1 revenue2,3991,342+79%Q2 revenue3,0341,770+71%Q3 revenue2,0772,249-8%Q4 revenue3,0092,071+45%Full-year…
Read More » -
Financial
Spineway-Shares reverse split
Reverse split by exchange of 2,000 existing shares for 1 new share Start of share split period: January 25, 2024 Effective…
Read More » -
Spine
SPINEWAY : International rollout of the VEOS implant range – First implants in Spain – New approvals in Colombia and Indonesia
Ecully, November 24, 2023 – The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders,…
Read More » -
Spine
Deputy Chief Executive Officer’s appointment
Appointment of Sandrine Carleas Deputy Chief Executive Officer Ecully, November 7, 2023-The Spineway Group, a specialist in innovative implants for…
Read More » -
Spine
Spineway- US 2023 NASS conference: VEOS System
VEOS system well perceived at the NASS 2023 conferencein the United States Sales growth in France Ecully, Novembre 2, 2023…
Read More » -
Regulatory
Spineway-VEOS FDA 510(k) clearance
Spineway obtains 510(k) clearance from the FDAfor its VEOS spinal fixation system Ecully, October 19, 2023- Spineway Group, a specialist…
Read More » -
Financial
SPINEWAY-Revenue growth as of September 2023 by 40%
Ecully, October 13, 2023 9-month revenue up 40% at €7.5 million In thousands of eurosUnaudited data20232022% changeQ1 revenue2,3991,342+79%Q2 revenue3,0341,770+71%Q3 revenue2,0772,249-8%9M…
Read More » -
Financial
Spineway 2023 half year results
Ecully, September 19, 2023 H1 2023 results Revenue growth in H1 (+75%) Gross margin of €3.9m (72% of revenue) Continued investment…
Read More »